Cargando…
Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome
TAFRO syndrome have been proposed as a rare variant of Castleman's disease. This article reports a case of a 56-year-old man with TAFRO syndrome who was successfully treated with thalidomide in spite of the refractoriness to prednisolone and tocilizumab. Thalidomide may be one of the treatment...
Autores principales: | Tatekawa, Shotaro, Umemura, Koji, Fukuyama, Ryuichi, Kohno, Akio, Taniwaki, Masafumi, Kuroda, Junya, Morishita, Yoshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498865/ https://www.ncbi.nlm.nih.gov/pubmed/26185651 http://dx.doi.org/10.1002/ccr3.284 |
Ejemplares similares
-
Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure
por: Aoki, Tatsuya, et al.
Publicado: (2017) -
Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide
por: Kikuchi, Taku, et al.
Publicado: (2017) -
TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin
por: Takayama, Yusuke, et al.
Publicado: (2017) -
TAFRO Syndrome
por: Fujikawa, Hirohisa, et al.
Publicado: (2020) -
An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy
por: Sakashita, Kentaro, et al.
Publicado: (2016)